Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.
Zhong P, Nakata K, Oyama K, Higashijima N, Sagara A, Date S, Luo H, Hayashi M, Kubo A, Wu C, He S, Yamamoto T, Koikawa K, Iwamoto C, Abe T, Ikenaga N, Ohuchida K, Morisaki T, Oda Y, Kuba K, Nakamura M.
Zhong P, et al. Among authors: sagara a.
J Exp Clin Cancer Res. 2024 May 8;43(1):138. doi: 10.1186/s13046-024-03060-5.
J Exp Clin Cancer Res. 2024.
PMID: 38715057
Free PMC article.